Austco Healthcare Limited

ASX:AHC Stock Report

Market Cap: AU$65.7m

Austco Healthcare Management

Management criteria checks 3/4

Austco Healthcare's CEO is Clayton Astles, appointed in Jul 2015, has a tenure of 8.83 years. total yearly compensation is A$914.99K, comprised of 61.1% salary and 38.9% bonuses, including company stock and options. directly owns 1.15% of the company’s shares, worth A$753.54K. The average tenure of the management team and the board of directors is 5.6 years and 8.6 years respectively.

Key information

Clayton Astles

Chief executive officer

AU$915.0k

Total compensation

CEO salary percentage61.1%
CEO tenure8.8yrs
CEO ownership1.1%
Management average tenure5.6yrs
Board average tenure8.6yrs

Recent management updates

Shareholders May Not Be So Generous With Austco Healthcare Limited's (ASX:AHC) CEO Compensation And Here's Why

Oct 25
Shareholders May Not Be So Generous With Austco Healthcare Limited's (ASX:AHC) CEO Compensation And Here's Why

Recent updates

Austco Healthcare (ASX:AHC) Could Be Struggling To Allocate Capital

Jan 05
Austco Healthcare (ASX:AHC) Could Be Struggling To Allocate Capital

Shareholders May Not Be So Generous With Austco Healthcare Limited's (ASX:AHC) CEO Compensation And Here's Why

Oct 25
Shareholders May Not Be So Generous With Austco Healthcare Limited's (ASX:AHC) CEO Compensation And Here's Why

Investors Will Want Austco Healthcare's (ASX:AHC) Growth In ROCE To Persist

Nov 24
Investors Will Want Austco Healthcare's (ASX:AHC) Growth In ROCE To Persist

Returns Are Gaining Momentum At Austco Healthcare (ASX:AHC)

Aug 23
Returns Are Gaining Momentum At Austco Healthcare (ASX:AHC)

With EPS Growth And More, Austco Healthcare (ASX:AHC) Makes An Interesting Case

Jul 01
With EPS Growth And More, Austco Healthcare (ASX:AHC) Makes An Interesting Case

There's Been No Shortage Of Growth Recently For Austco Healthcare's (ASX:AHC) Returns On Capital

Apr 12
There's Been No Shortage Of Growth Recently For Austco Healthcare's (ASX:AHC) Returns On Capital

Investors Will Want Austco Healthcare's (ASX:AHC) Growth In ROCE To Persist

Dec 01
Investors Will Want Austco Healthcare's (ASX:AHC) Growth In ROCE To Persist

Returns On Capital Are Showing Encouraging Signs At Austco Healthcare (ASX:AHC)

Jul 07
Returns On Capital Are Showing Encouraging Signs At Austco Healthcare (ASX:AHC)

Here's Why I Think Austco Healthcare (ASX:AHC) Might Deserve Your Attention Today

Apr 29
Here's Why I Think Austco Healthcare (ASX:AHC) Might Deserve Your Attention Today

Can Austco Healthcare (ASX:AHC) Continue To Grow Its Returns On Capital?

Mar 16
Can Austco Healthcare (ASX:AHC) Continue To Grow Its Returns On Capital?

Will Weakness in Austco Healthcare Limited's (ASX:AHC) Stock Prove Temporary Given Strong Fundamentals?

Feb 18
Will Weakness in Austco Healthcare Limited's (ASX:AHC) Stock Prove Temporary Given Strong Fundamentals?

Does Austco Healthcare (ASX:AHC) Deserve A Spot On Your Watchlist?

Jan 29
Does Austco Healthcare (ASX:AHC) Deserve A Spot On Your Watchlist?

A Quick Analysis On Austco Healthcare's (ASX:AZV) CEO Salary

Jan 11
A Quick Analysis On Austco Healthcare's (ASX:AZV) CEO Salary

Are Austco Healthcare's (ASX:AHC) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 25
Are Austco Healthcare's (ASX:AHC) Statutory Earnings A Good Guide To Its Underlying Profitability?

Returns On Capital - An Important Metric For Austco Healthcare (ASX:AHC)

Dec 07
Returns On Capital - An Important Metric For Austco Healthcare (ASX:AHC)

Are Robust Financials Driving The Recent Rally In Azure Healthcare Limited's (ASX:AZV) Stock?

Nov 20
Are Robust Financials Driving The Recent Rally In Azure Healthcare Limited's (ASX:AZV) Stock?

CEO Compensation Analysis

How has Clayton Astles's remuneration changed compared to Austco Healthcare's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

AU$2m

Sep 30 2023n/an/a

AU$2m

Jun 30 2023AU$915kAU$559k

AU$2m

Mar 31 2023n/an/a

AU$2m

Dec 31 2022n/an/a

AU$2m

Sep 30 2022n/an/a

AU$2m

Jun 30 2022AU$857kAU$496k

AU$2m

Mar 31 2022n/an/a

AU$3m

Dec 31 2021n/an/a

AU$4m

Sep 30 2021n/an/a

AU$4m

Jun 30 2021AU$791kAU$497k

AU$3m

Mar 31 2021n/an/a

AU$3m

Dec 31 2020n/an/a

AU$3m

Sep 30 2020n/an/a

AU$3m

Jun 30 2020AU$875kAU$547k

AU$3m

Mar 31 2020n/an/a

AU$2m

Dec 31 2019n/an/a

AU$2m

Sep 30 2019n/an/a

AU$1m

Jun 30 2019AU$771kAU$570k

AU$637k

Mar 31 2019n/an/a

AU$465k

Dec 31 2018n/an/a

AU$292k

Sep 30 2018n/an/a

AU$743k

Jun 30 2018AU$675kAU$494k

AU$1m

Mar 31 2018n/an/a

-AU$115k

Dec 31 2017n/an/a

-AU$1m

Sep 30 2017n/an/a

-AU$4m

Jun 30 2017AU$703kAU$504k

-AU$6m

Compensation vs Market: Clayton's total compensation ($USD601.73K) is above average for companies of similar size in the Australian market ($USD295.42K).

Compensation vs Earnings: Clayton's compensation has been consistent with company performance over the past year.


CEO

Clayton Astles

8.8yrs

Tenure

AU$914,993

Compensation

Mr. Clayton Astles has been the Chief Executive Officer of Austco Healthcare Limited (formerly known as Azure Healthcare Limited) since July 31, 2015 and serves as its Managing Director. Mr. Astles serves...


Leadership Team

NamePositionTenureCompensationOwnership
Clayton Astles
CEO, MD & Executive Director8.8yrsAU$914.99k1.15%
A$ 753.5k
Brendan Maher
CFO & Company Secretary5.6yrsAU$473.73k0.50%
A$ 330.7k
Andrew Hall
Chief Commercial Officer1.8yrsno datano data

5.6yrs

Average Tenure

Experienced Management: AHC's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Clayton Astles
CEO, MD & Executive Director8.8yrsAU$914.99k1.15%
A$ 753.5k
J. Burns
Independent Non-Executive Director8.6yrsAU$70.00k0.35%
A$ 233.0k
Anthony Glenning
Independent Non-Executive Director5.7yrsAU$70.00k0.29%
A$ 192.4k
Graeme Billings
Independent Non-Executive Chairman8.6yrsAU$85.00k0.15%
A$ 96.5k

8.6yrs

Average Tenure

Experienced Board: AHC's board of directors are considered experienced (8.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.